This inventor holds 1 USPTO granted patent. Top assignee: School Juridical Person Kitasato Institute. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Daisuke Matsuda: Innovator in Arteriosclerosis Treatment
Introduction
Daisuke Matsuda is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of medicine, particularly in the prevention and treatment of arteriosclerosis. His innovative approach offers a mechanism that differs from traditional statin drugs.
Latest Patents
Matsuda holds a patent for a compound titled "Pyripyropene derivative having ACAT2 inhibiting activity and stable to metabolizing enzymes." This compound is effective in preventing and treating arteriosclerosis. The patent describes a formula that includes various acyloxy groups and other chemical structures that enhance its efficacy.
Career Highlights
Daisuke Matsuda is affiliated with the Kitasato Institute, a prominent research institution. His work focuses on developing novel therapeutic agents that can provide alternative solutions for patients suffering from arteriosclerosis.
Collaborations
Matsuda has collaborated with esteemed colleagues such as Hiroshi Tomoda and Tohru Nagamitsu. Their combined expertise has contributed to advancing research in the field of cardiovascular health.
Conclusion
Daisuke Matsuda's innovative work in developing new treatments for arteriosclerosis showcases his commitment to improving patient outcomes. His contributions to medical science are invaluable and highlight the importance of continued research in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile